BSW Biologic Treatment Pathway for Migraine Prevention in Adults
Migraine chronic episodic biologic blueteq botulinum botox erenumab galcanezumab fremenezumab ajovy aimovig emgality
Blueteq
Blueteq enabled forms – Masters List
Blueteq ophthalmology dermatology gastroenterology rheumatology haematology
Blueteq Ophthalmology Pathway
DMO CRVO BVRO CNV choroidal nevascularisation aflibercept ranibizumab AMD Dexamethasone Fluocinolone
BSW ITP Treatment Pathway for Adult Patients
thrombocytopenic purpura Idiopathic ITP Eltrombopag Romiplostim
Atopic Dermatitis treatment pathway
Dupilumab atopic dermatitis eczema biologic blueteq baricitinib olimiant dupixent
Blueteq gastroenterology biologic form schematic
Crohn’s disease Ulcerative Colitis Biologic Infliximab Adalimumab Golimumab Vedolizumab Ustekinumab
PCSK9 inhibitors – prescribing summary
primary hypercholesterolaemia mixed dyslipidaemia Alirocumab Evolocumab cholesterol
Crohn’s Disease BSW STP Biologic Commissioning Pathway
Crohn’s Disease Biologic Infliximab Adalimumab Ustekinumab Vedolizumab crohns
Ulcerative Colitis Disease BSW STP Biologic/Biosimilar Commissioning Pathway
Ulcerative Colitis Biologic Infliximab Adalimumab Golimumab Vedolizumab
Plaque Psoriasis (Moderate to Servere) Biologic Treatment Pathway in Adults
Plaque Psoriasis Biologic